Share price development
Listed on Euronext Paris
IPO on 24 October 1997
ISIN code: FR0014000MR3
Ticker codes: Reuters EUFI.PA, Bloomberg ERF FP
Euronext Paris
CAC 40, EURONEXT 100, SBF 120, SBF TOP 80 EW, CAC ALL SHARES, CAC ALL-TRADABLE, CAC HEALTH CARE, CAC LARGE 60.
Euronext Amsterdam
EN EUR N100 EW, EN EUROZONE 150 EW, EN EUROPE 500, EN EUROZONE 300, EN EZ 100 ESG.
Other
MSCI Europe, STOXX Europe 600, S&P Europe 350
Industry classification
GICS Sector: Healthcare
GICS Industry: Life Sciences Tools & Services
Ownership structure
Free float
Martin family
More information on the ownership structure can be found in Eurofins’ most recent Annual and Half-year Reports.
Gross dividend of EUR 0.60 per share for the financial year ended 31 December 2024.
EX date
28/04/2025
Record date
29/04/2025
Pay date
30/04/2025
Analyst coverage
Eurofins Scientific S.E. is covered by the analysts listed below.
| AlphaValue | Nupur Gupta |
| Barclays | James Rose |
| Berenberg | Carl Raynsford |
| BernsteinSG | Delphine Le Louet |
| CIC Market Solutions | Arnaud Cadart |
| Citi | Arthur Truslove |
| Deutsche Bank | Ben Wild |
| BNP Paribas Exane | Tom Burlton |
| Gilbert Dupont | Guillaume Cuvillier |
| Goldman Sachs | Suhasini Varanasi |
| Jefferies | Allen Wells |
| Kepler Cheuvreux | Pablo Cuadrado |
| Morgan Stanley | Remi Grenu |
| Morningstar | Jay Lee |
| ODDO BHF | Geoffroy Michalet |
| Redburn | Neil Tyler |